Full Job Description
New Jersey, US | full time | Job ID: 11923
About the role:
Built on a strong scientific, technological, and clinical foundation, we are building a commercial organization to launch and drive revenue for our oncology portfolio. As Senior Director, you will lead strategy for our early-stage pipeline, spanning all assets from preclinical candidates through early Phase 2, so that the most promising science becomes differentiated medicines for patients.
You will bring a patient-centered, externally focused approach, partnering with oncology clinicians to understand their needs and those of their patients. You will work closely with Research and Development to shape early clinical programs that are designed for later regulatory and commercial success, and you will help the organization decide where to invest. As a senior leader within Global Product Strategy, you will have visibility at all levels of the organization.
Your contribution:
37Set the global product strategy for the early portfolio, covering all assets from preclinical candidates through early Phase 2, across multiple modalities and tumor types.
37Define target product profiles, indication prioritization, and differentiation strategy for each asset, grounded in unmet patient need and the evolving competitive and treatment landscape.
37Partner with Research, Translational, and Clinical Development to design early clinical plans, including biomarker and patient-selection strategies, that create a clear path to proof of concept and to later-stage regulatory and commercial success.
37Build and maintain go/no-go criteria, early commercial assessments, and market and forecast models to inform portfolio prioritization and investment decisions.
37Gather insights from oncology clinicians, KOLs, patients, and payers early in development to test assumptions and shape clinical programs.
37Monitor scientific, clinical, and competitor trends, and translate them into actionable implications for asset strategy and portfolio planning.
37Support business development and partnering efforts by providing strategic and commercial assessments of internal and external opportunities.
37Where BioNTech has co-development or co-commercialization rights, ensure alignment with partners on asset strategy and resources.
37Prepare assets for a smooth transition into late-stage development by working with late-stage Global Product Strategy teams, Regulatory Affairs, Medical Affairs, and Market Access.
37Lead, coach, and mentor team members, and build a high-performing, collaborative early-asset strategy function.
37Own budget planning and tracking for the function, and manage vendor partnerships so work is delivered on plan, cost-effectively, and within budget.
A good match:
37BS/BA with 10+ years in pharma or biotech and increasing levels of responsibility. Advanced degree a plus.
37Oncology experience, including immunotherapy; knowledge of novel modalities such as mRNA, antibody-drug conjugates, or cell therapy is a strong plus.
37Experience in early-stage asset strategy, early development, or translational strategy, with a record of helping advance assets from preclinical stage to clinical proof of concept.
37Working knowledge of drug development, regulatory pathways, and the reimbursement and healthcare environment, and how they shape early program design.
37Experience at both country/affiliate level and regional or global level, or equivalent breadth, preferred.
37Prior product launch experience is valued, as it informs how early programs are designed.
37Proven ability to influence and build alignment across R&D, commercial, and business development teams.
37Strong analytical, strategic, organizational, and collaboration skills.
Your benefits and remuneration:
Expected Pay Range: $198,900/year to $318,300/year + benefits, annual bonus & equity (bonus and equity is variable and dependent on company and individual performance). Compensation for the role will depend on several factors, including responsibilities of the job, education, experience, knowledge, skills, and abilities.
BioNTech US is committed to employee wellbeing and offers best-in-class benefits & HR programs to support an inclusive & diverse workforce. Salaried/Position-Targeted Hourly Employees working 30+ hours per week are eligible for our comprehensive benefits package. Benefits include but are not limited to:
37Medical, Dental and Vision Insurance
37Life, AD&D, Critical Illness Insurance
37Pre-tax HSA & FSA, DCRA Spending Accounts
37Employee Assistance & Concierge Program (EAP) available 24/7
37Parental and Childbirth Leave & Family Planning Assistance
37Sitterstream: Virtual Tutoring & Childcare Membership
37Paid Time Off: Vacation, Sick, Bereavement, Holidays (including Floating) & Year-End U.S. Shutdown.
37401(K) Plan with Company Match
37Tuition Reimbursement & Student Loan Assistance Programs
37Wellbeing Incentive Platforms & Incentives
37Professional Development Programs
37Commuting Allowance and subsidized parking
37Discounted Home, Auto & Pet Insurance
...and more! More details to be shared.
Berkeley Heights is New Jersey's growing hub within the life sciences industry and has already demonstrated the state's commitment to innovation, collaboration, and excellence within the field. New Jersey's integrated approach to biotechnology and pharmaceuticals harmonizes academic rigor, industrial capability, and government support to create thriving conditions for a growing ecosystem. Cultivating an environment that seamlessly integrates cutting-edge research, robust manufacturing capabilities, and a dynamic business landscape, New Jersey has become a powerhouse in pharmaceuticals, biotechnology, and medical technology. As this region of New Jersey continues to develop, it stands ready to shape the future of medical science and technology, driving progress and improving health outcomes worldwide.
Apply now - We look forward to your application!
Apply for our New Jersey, US location and simply send us your documents using our online form.